nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.166	0.198	CbGbCtD
Triflupromazine—BCHE—Ramipril—type 2 diabetes mellitus	0.157	0.186	CbGbCtD
Triflupromazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.148	0.176	CbGbCtD
Triflupromazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0898	0.107	CbGbCtD
Triflupromazine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0777	0.0924	CbGbCtD
Triflupromazine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0692	0.0824	CbGbCtD
Triflupromazine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0501	0.0595	CbGbCtD
Triflupromazine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0344	0.0409	CbGbCtD
Triflupromazine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0256	0.0305	CbGbCtD
Triflupromazine—ABCB1—Losartan—type 2 diabetes mellitus	0.0234	0.0279	CbGbCtD
Triflupromazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000422	0.0449	CrCbGaD
Triflupromazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000357	0.038	CrCbGaD
Triflupromazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000342	0.0364	CrCbGaD
Triflupromazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000337	0.0359	CrCbGaD
Triflupromazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000333	0.0355	CrCbGaD
Triflupromazine—Cinacalcet—CYP1A2—type 2 diabetes mellitus	0.00033	0.0352	CrCbGaD
Triflupromazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000329	0.035	CrCbGaD
Triflupromazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000264	0.0281	CrCbGaD
Triflupromazine—Cinacalcet—CYP3A4—type 2 diabetes mellitus	0.000219	0.0233	CrCbGaD
Triflupromazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000201	0.0214	CrCbGaD
Triflupromazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000194	0.0207	CrCbGaD
Triflupromazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	0.000191	0.0203	CrCbGaD
Triflupromazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	0.000176	0.0187	CrCbGaD
Triflupromazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	0.000174	0.0186	CrCbGaD
Triflupromazine—Propiomazine—HTR2C—type 2 diabetes mellitus	0.000169	0.018	CrCbGaD
Triflupromazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	0.000166	0.0176	CrCbGaD
Triflupromazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	0.000164	0.0175	CrCbGaD
Triflupromazine—Clomipramine—HTR2C—type 2 diabetes mellitus	0.000161	0.0171	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	0.00016	0.017	CrCbGaD
Triflupromazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	0.000157	0.0167	CrCbGaD
Triflupromazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	0.000153	0.0163	CrCbGaD
Triflupromazine—Thioridazine—HTR2C—type 2 diabetes mellitus	0.000151	0.0161	CrCbGaD
Triflupromazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	0.000151	0.0161	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	0.000144	0.0154	CrCbGaD
Triflupromazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	0.000143	0.0152	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	0.00014	0.0149	CrCbGaD
Triflupromazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	0.000139	0.0148	CrCbGaD
Triflupromazine—Perphenazine—HTR2C—type 2 diabetes mellitus	0.000139	0.0148	CrCbGaD
Triflupromazine—Promazine—ADRA2A—type 2 diabetes mellitus	0.000136	0.0145	CrCbGaD
Triflupromazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	0.000133	0.0141	CrCbGaD
Triflupromazine—Desipramine—HTR2C—type 2 diabetes mellitus	0.000129	0.0138	CrCbGaD
Triflupromazine—Diltiazem—CYP3A4—type 2 diabetes mellitus	0.000128	0.0136	CrCbGaD
Triflupromazine—Promazine—HTR2C—type 2 diabetes mellitus	0.000125	0.0133	CrCbGaD
Triflupromazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	0.000121	0.0129	CrCbGaD
Triflupromazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	0.00012	0.0128	CrCbGaD
Triflupromazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	0.00012	0.0127	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	0.000115	0.0122	CrCbGaD
Triflupromazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	0.000114	0.0122	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	0.00011	0.0117	CrCbGaD
Triflupromazine—Imipramine—HTR2C—type 2 diabetes mellitus	0.00011	0.0117	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	0.000109	0.0116	CrCbGaD
Triflupromazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	0.000106	0.0113	CrCbGaD
Triflupromazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	0.000105	0.0112	CrCbGaD
Triflupromazine—Desipramine—CYP2E1—type 2 diabetes mellitus	0.000103	0.0109	CrCbGaD
Triflupromazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	0.000102	0.0108	CrCbGaD
Triflupromazine—Desipramine—CYP1A2—type 2 diabetes mellitus	9.75e-05	0.0104	CrCbGaD
Triflupromazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	9.7e-05	0.0103	CrCbGaD
Triflupromazine—Promazine—CYP1A2—type 2 diabetes mellitus	9.45e-05	0.0101	CrCbGaD
Triflupromazine—Acepromazine—ALB—type 2 diabetes mellitus	9.21e-05	0.0098	CrCbGaD
Triflupromazine—Thioproperazine—ALB—type 2 diabetes mellitus	9e-05	0.00958	CrCbGaD
Triflupromazine—Pipotiazine—ALB—type 2 diabetes mellitus	8.86e-05	0.00943	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	8.74e-05	0.0093	CrCbGaD
Triflupromazine—Imipramine—CYP2E1—type 2 diabetes mellitus	8.69e-05	0.00926	CrCbGaD
Triflupromazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	8.31e-05	0.00885	CrCbGaD
Triflupromazine—Imipramine—CYP1A2—type 2 diabetes mellitus	8.27e-05	0.0088	CrCbGaD
Triflupromazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	8.02e-05	0.00854	CrCbGaD
Triflupromazine—Clomipramine—ALB—type 2 diabetes mellitus	7e-05	0.00745	CrCbGaD
Triflupromazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	6.94e-05	0.00739	CrCbGaD
Triflupromazine—Desipramine—CYP3A4—type 2 diabetes mellitus	6.46e-05	0.00687	CrCbGaD
Triflupromazine—Promazine—CYP3A4—type 2 diabetes mellitus	6.25e-05	0.00666	CrCbGaD
Triflupromazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	5.5e-05	0.00586	CrCbGaD
Triflupromazine—Imipramine—CYP3A4—type 2 diabetes mellitus	5.48e-05	0.00583	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—type 2 diabetes mellitus	4.8e-05	0.00511	CrCbGaD
Triflupromazine—HTR2B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.61e-05	0.000107	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.6e-05	0.000106	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—C3—type 2 diabetes mellitus	1.6e-05	0.000106	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.58e-05	0.000106	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.58e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.58e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.58e-05	0.000105	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.57e-05	0.000105	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.57e-05	0.000104	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.57e-05	0.000104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.56e-05	0.000104	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.56e-05	0.000104	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.54e-05	0.000103	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.54e-05	0.000103	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.53e-05	0.000102	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.53e-05	0.000102	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.52e-05	0.000102	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.52e-05	0.000101	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.52e-05	0.000101	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.51e-05	0.000101	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.51e-05	0.000101	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.49e-05	9.95e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.49e-05	9.91e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.49e-05	9.91e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.49e-05	9.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.48e-05	9.9e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	1.48e-05	9.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.47e-05	9.8e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.47e-05	9.8e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.46e-05	9.71e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.46e-05	9.71e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.46e-05	9.71e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—INS—type 2 diabetes mellitus	1.45e-05	9.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.45e-05	9.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.45e-05	9.67e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.45e-05	9.67e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.44e-05	9.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.44e-05	9.6e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.44e-05	9.59e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.43e-05	9.56e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.43e-05	9.53e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.42e-05	9.49e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.42e-05	9.47e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.42e-05	9.47e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.42e-05	9.47e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-05	9.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.41e-05	9.42e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.41e-05	9.38e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.41e-05	9.37e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.4e-05	9.35e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.4e-05	9.35e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.4e-05	9.34e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.4e-05	9.34e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.4e-05	9.31e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.39e-05	9.3e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.39e-05	9.29e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.39e-05	9.26e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.39e-05	9.26e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-05	9.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.38e-05	9.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.37e-05	9.17e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.37e-05	9.15e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.37e-05	9.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.35e-05	9.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.35e-05	9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.35e-05	8.99e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—type 2 diabetes mellitus	1.35e-05	8.98e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.34e-05	8.93e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	1.33e-05	8.89e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.33e-05	8.89e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.33e-05	8.88e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.33e-05	8.84e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.32e-05	8.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-05	8.78e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-05	8.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.31e-05	8.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.31e-05	8.74e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.3e-05	8.68e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-05	8.68e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-05	8.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.29e-05	8.62e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.28e-05	8.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.28e-05	8.55e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-05	8.5e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-05	8.5e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—type 2 diabetes mellitus	1.27e-05	8.47e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.27e-05	8.44e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.26e-05	8.42e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.26e-05	8.42e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.26e-05	8.38e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.25e-05	8.33e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-05	8.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.23e-05	8.22e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.23e-05	8.2e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.23e-05	8.19e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.23e-05	8.18e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.22e-05	8.15e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.21e-05	8.09e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.21e-05	8.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	1.2e-05	8.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.19e-05	7.95e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-05	7.87e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-05	7.87e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.18e-05	7.87e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-05	7.78e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.17e-05	7.78e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.16e-05	7.76e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.15e-05	7.66e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.15e-05	7.65e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.14e-05	7.64e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.13e-05	7.51e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.12e-05	7.5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.12e-05	7.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.12e-05	7.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.12e-05	7.48e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.12e-05	7.47e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.11e-05	7.42e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.11e-05	7.42e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-05	7.41e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.11e-05	7.4e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.11e-05	7.4e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.11e-05	7.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.11e-05	7.38e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.1e-05	7.35e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.1e-05	7.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.1e-05	7.32e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-05	7.26e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-05	7.26e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.09e-05	7.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.09e-05	7.24e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.08e-05	7.23e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.08e-05	7.23e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.08e-05	7.23e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.07e-05	7.15e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.07e-05	7.13e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.06e-05	7.06e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.05e-05	6.99e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.04e-05	6.92e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.04e-05	6.91e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.02e-05	6.82e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-05	6.75e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-05	6.73e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1e-05	6.68e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1e-05	6.67e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.95e-06	6.64e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.9e-06	6.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.79e-06	6.53e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.7e-06	6.47e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.67e-06	6.45e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.66e-06	6.45e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	9.58e-06	6.39e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.54e-06	6.36e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.47e-06	6.32e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.45e-06	6.3e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.43e-06	6.29e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.41e-06	6.28e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.39e-06	6.26e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	9.38e-06	6.26e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.37e-06	6.25e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.29e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.27e-06	6.18e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.26e-06	6.18e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	9.26e-06	6.18e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.23e-06	6.16e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.22e-06	6.15e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.18e-06	6.13e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.11e-06	6.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.07e-06	6.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.06e-06	6.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.02e-06	6.02e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.95e-06	5.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.95e-06	5.97e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.93e-06	5.96e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.92e-06	5.95e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.91e-06	5.94e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.83e-06	5.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.8e-06	5.87e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.75e-06	5.84e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.73e-06	5.82e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.66e-06	5.78e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.61e-06	5.75e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.5e-06	5.67e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.5e-06	5.67e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.47e-06	5.65e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.4e-06	5.61e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.4e-06	5.61e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.33e-06	5.56e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.3e-06	5.54e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.23e-06	5.49e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.22e-06	5.49e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.22e-06	5.49e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	8.21e-06	5.48e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.12e-06	5.42e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.12e-06	5.42e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.02e-06	5.35e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	7.91e-06	5.28e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.8e-06	5.21e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.74e-06	5.16e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.65e-06	5.1e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	7.64e-06	5.1e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.36e-06	4.91e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.23e-06	4.82e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.21e-06	4.81e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.2e-06	4.8e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.13e-06	4.76e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	7.09e-06	4.73e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.09e-06	4.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.05e-06	4.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.98e-06	4.66e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.96e-06	4.64e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.94e-06	4.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.89e-06	4.6e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.85e-06	4.57e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.74e-06	4.5e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.67e-06	4.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.6e-06	4.4e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.54e-06	4.36e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.53e-06	4.35e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.51e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.5e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.44e-06	4.3e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.4e-06	4.27e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.32e-06	4.21e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.22e-06	4.15e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.22e-06	4.15e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.21e-06	4.15e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.08e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.05e-06	4.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	6e-06	4.01e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.92e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.88e-06	3.92e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-06	3.91e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.85e-06	3.9e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.69e-06	3.8e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.56e-06	3.71e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.54e-06	3.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.45e-06	3.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.44e-06	3.63e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.42e-06	3.62e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.37e-06	3.58e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.33e-06	3.56e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.26e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.12e-06	3.41e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.19e-06	2.79e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.1e-06	2.73e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.04e-06	2.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.86e-06	2.58e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.78e-06	2.52e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.73e-06	2.49e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.86e-06	1.91e-05	CbGpPWpGaD
